Effects of Abatacept in Patients With Early Rheumatoid Arthritis
Clinical trial NCT02504268 · COMPLETED
Trial details
- NCT number
- NCT02504268
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-03
- Primary completion
- 2017-01-16
- Enrollment
- 994
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.